C1ORF128 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.562000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.225200E-01
Normal-vs-Stage2
4.692800E-01
Normal-vs-Stage3
3.413800E-01
Normal-vs-Stage4
4.198600E-01
Stage1-vs-Stage2
9.205800E-01
Stage1-vs-Stage3
5.213000E-01
Stage1-vs-Stage4
7.139500E-02
Stage2-vs-Stage3
3.966600E-01
Stage2-vs-Stage4
3.700000E-02
Stage3-vs-Stage4
9.695800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.956000E-01
Normal-vs-AfricanAmerican
6.128000E-01
Normal-vs-Asian
3.438800E-01
Caucasian-vs-AfricanAmerican
8.357800E-01
Caucasian-vs-Asian
3.563600E-01
AfricanAmerican-vs-Asian
7.022800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.560800E-01
Normal-vs-Female
5.706800E-01
Male-vs-Female
9.929800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.174600E-01
Normal-vs-Age(41-60Yrs)
8.699400E-01
Normal-vs-Age(61-80Yrs)
4.816600E-01
Normal-vs-Age(81-100Yrs)
2.869600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.367800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.998200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.585200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.501600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.404300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.924600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.254400E-01
Normal-vs-Daily Drinker
8.818600E-01
Normal-vs-Weekly Drinker
5.779600E-01
Normal-vs-Occasional Drinker
9.774200E-01
Normal-vs-Social Drinker
2.063400E-01
Non Drinker-vs-Daily Drinker
2.240300E-02
Non Drinker-vs-Weekly Drinker
4.189200E-01
Non Drinker-vs-Occasional Drinker
1.458080E-02
Non Drinker-vs-Social Drinker
3.506200E-01
Daily Drinker-vs-Weekly Drinker
3.422400E-01
Daily Drinker-vs-Occasional Drinker
8.066600E-01
Daily Drinker-vs-Social Drinker
1.315200E-01
Weekly Drinker-vs-Occasional Drinker
2.664800E-01
Weekly Drinker-vs-Social Drinker
8.616000E-01
Occasional Drinker-vs-Social Drinker
6.737500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.267400E-01
Normal-vs-Grade 2
9.291000E-01
Normal-vs-Grade 3
8.678400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.647200E-01
Grade 1-vs-Grade 3
3.356400E-01
Grade 1-vs-Grade 4
9.267400E-01
Grade 2-vs-Grade 3
4.597600E-02
Grade 2-vs-Grade 4
9.291000E-01
Grade 3-vs-Grade 4
8.678400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.293600E-01
Normal-vs-NonDiabetic
5.781600E-01
Diabetic-vs-NonDiabetic
5.047000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.223200E-01
Normal-vs-NoPancreatitis
5.442400E-01
Pancreatitis-vs-NoPancreatitis
3.026600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.545800E-01
Normal-vs-N1
5.157200E-01
N0-vs-N1
5.888200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.063800E-01
Normal-vs-TP53-NonMutant
5.588200E-01
TP53-Mutant-vs-TP53-NonMutant
7.802100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
